UWA AMOJI: Open Payments
NPI 1265910608 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 8 payments from 6 companies in 2025. Trend: 2023 $151 · 2024 $194 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| ABBVIE INC. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Wegovy, Rybelsus, CAPLYTA, VRAYLAR, JARDIANCE, MOUNJARO, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
